LynxCare Blog

Discover how we help hospitals and life sciences collaborate under a federated model, and generate qualitative RWE at scale. Let’s grow the European Health Data Space, together.

Filter

Reset all
Show Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 23, 2023 - 1 min. read
Clinical Insights in Oncology
This is some text inside of a div block.
This is some text inside of a div block.
LynxCare's comprehensive datasets within its European hospital network offer fresh insights into Immuno-Oncology, Breast Cancer, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma (MM), including comorbidity factors, treatment patterns, and staging.
re- re2-
Read more
Jun 27, 2023 - 4 min. read
The European Health Data Space: an opportunity to improve health for all.
This is some text inside of a div block.
This is some text inside of a div block.
In May 2022, the European Commission announced the launch of the European Health Data Space (EHDS), one of the central building blocks of a strong European Health Union. The EHDS will help the EU to achieve a quantum leap forward in the way healthcare is provided to people across Europe.
re- re2-
Read more
Latest news - Apr 17, 2023 - 5 min. read
Announcing LynxCare’s €20M series A Funding: the Next Step Towards More Transparency for Patients
Feb 08, 2024 - 2 min. read
CLL Patient Journey Insights from Fresh Quality-Assured Real-World Data
This is some text inside of a div block.
This is some text inside of a div block.
Our granular and quality-controlled real-world dataset allows in-depth analysis and research into the CLL patient journey.
re- re2-
Read more
Feb 01, 2024 - 2 min. read
Your platform for extensive breast cancer analysis and research – Explore LynxCare’s Breast Cancer Datasets
This is some text inside of a div block.
This is some text inside of a div block.
67% stage I-II breast cancer patients, 14% stage III-IV breast cancer patients - discover more LynxCare datasets insights.
re- re2-
Read more
Jan 25, 2024 - 2 min. read
Analyze adverse events and treatment patterns in Immuno-Oncology through LynxCare's Real-World Datasets
This is some text inside of a div block.
This is some text inside of a div block.
Gain fresh insights into the relationship of specific comorbidities, adverse events and biomarkers with immuno-oncology prognosis through LynxCare's European data asset.
re- re2-
Read more
Jan 16, 2024 - 1 min. read
LynxCare successfully renews ISO 27001 and NEN 7510 certifications
This is some text inside of a div block.
This is some text inside of a div block.
We are proud to share that we have successfully renewed our ISO 27001 and NEN 7510 certifications. These certifications are not just badges, but a reflection of our commitment to maintaining the highest information security standards in healthcare!
re- re2-
Read more
Nov 23, 2023 - 1 min. read
Clinical Insights in Oncology
This is some text inside of a div block.
This is some text inside of a div block.
LynxCare's comprehensive datasets within its European hospital network offer fresh insights into Immuno-Oncology, Breast Cancer, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma (MM), including comorbidity factors, treatment patterns, and staging.
re- re2-
Read more
Nov 09, 2023 - 1 min. read
Unlock Insights in Breast Cancer
This is some text inside of a div block.
This is some text inside of a div block.
LynxCare's comprehensive data asset offers fresh insights into breast cancer, including comorbidity factors, treatment patterns, and staging. With over 4800 estimated patients and 598 endpoints measured, our granular and quality-controlled real-world dataset can unlock invaluable insights into the treatment and prognosis of breast cancer patients, empowering clinicians to make informed decisions.
re- re2-
Read more

Curious what LynxCare can do for you?

For Life Science organizations

RWE you can trust. At scale.

Discover how
For Healthcare organizations

Put your data to work.

Discover how

”We're an active contributor to establishing the pan-European Health Data Evidence Network (EHDEN) and are eager to contribute to building the European Health Data Space to make a more inclusive European healthcare system for all patients.”

Georges De Feu
Co-founder & CEO, LynxCare